Value co-creation in healthcare: evidence from innovative therapeutic alternatives for hereditary angioedema
Abstract Background Our research focuses on the co-creation of value in healthcare with reference to a case of hereditary angioedema with C1 inhibitor deficiency (C1-INH-HAE). Our work is mainly based on the concept of value co-creation in healthcare. The aim of this study is to assess the impact of...
Main Authors: | Rosanna Spanò, Nadia Di Paola, Maria Bova, Alessandro Barbarino |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-07-01
|
Series: | BMC Health Services Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12913-018-3389-y |
Similar Items
-
The Genetics of Hereditary Angioedema: A Review
by: Rosa Santacroce, et al.
Published: (2021-05-01) -
Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey
by: Andrea Zanichelli, et al.
Published: (2018-10-01) -
Diagnosis and screening of patients with hereditary angioedema in primary care
by: Henao MP, et al.
Published: (2016-05-01) -
DEFINING THE BIOLOGICAL FUNCTION OF C1 INHIBITOR IN HEREDITARY ANGIOEDEMA
by: HAN, EUN DUK
Published: (2002) -
Angioedema hereditário: considerações sobre terapia Therapeutic approach of hereditary angioedema
by: Kélem de Nardi Chagas, et al.
Published: (2004-09-01)